Daniel P Rossignol

USPTO Granted Patents = 17 (Patent Applications = 2)

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 3.7

ph-index = 10

Forward Citations = 242(Granted Patents)

Location History:

Andover, MA (US) (1996 - 2001)
Mahwah, NJ (US) (2001 - 2011)
Ridgefield Park, NJ (US) (2011 - 2013)

Company Filing History:

12 out of 677

Eisai Company, Limited

patents

5 out of 528

Eisai R&d Management Co., Ltd.

patents

Years Active: 1996-2013

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8603482 - Compositions and methods for cancer immunotherapy (2013-12-10),

2. 7994154 - Substituted liposaccharides useful in the treatment and prevention of endotoxemia (2011-08-09),

3. 7976852 - Compositions and methods for cancer immunotherapy (2011-07-12),

4. 7737129 - Substituted liposaccharides useful in the treatment and prevention of endotoxemia (2010-06-15),

5. 7348316 - Use of an anti-endotoxin drug in the prevention and treatment of disease (2008-03-25),

6. 6683063 - Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs (2004-01-27),

7. 6417172 - Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs (2002-07-09),

8. 6290973 - Immunological adjuvant compounds, compositions, and methods of use thereof (2001-09-18),

9. 6184366 - Substituted liposaccharides useful in the treatment and prevention of endotoxemia (2001-02-06),

10. 5952309 - Method for treating alcoholic liver disease (1999-09-14),

11. 5935938 - Substituted liposaccharides useful in the treatment and prevention of (1999-08-10),

12. 5843918 - Anti-endotoxin compounds (1998-12-01),

13. 5756718 - Anti-endotoxin compounds (1998-05-26),

14. 5750664 - Substituted liposaccharides useful in the treatment and prevention of (1998-05-12),

15. 5681824 - Substituted liposaccharides useful in the treatment and prevention of (1997-10-28),

Title: The Innovative Contributions of Daniel P. Rossignol

Introduction

Daniel P. Rossignol is a prominent inventor based in Mahwah, NJ (US), known for his significant contributions to the field of medical science. With a total of 17 patents to his name, he has made remarkable advancements, particularly in cancer immunotherapy and the treatment of endotoxemia.

Latest Patents

Among his latest patents, one notable invention is focused on compositions and methods for cancer immunotherapy. This invention relates to immunotherapeutic compounds and methods for stimulating an immune response in individuals at risk for developing cancer, those diagnosed with cancer, or patients undergoing treatment or recovery from cancer. The compounds can also be administered prophylactically to prevent or delay the onset of cancer. Another significant patent involves substituted liposaccharides that are useful in the treatment and prevention of endotoxemia. This includes novel substituted liposaccharides that serve as both prophylactic and affirmative treatments for conditions such as sepsis, septicemia, and various forms of septic shock. The patent also outlines methods for preparing these agents and their intermediates.

Career Highlights

Throughout his career, Daniel P. Rossignol has worked with esteemed organizations, including Eisai Company, Limited and Eisai R&D Management Co., Ltd. His work in these companies has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collabor

This text is generated by artificial intelligence and may not be accurate.